A qualified clinician can screen for contraindications, review interactions, and provide oversight that self-experimentation cannot
That said, patients with active diabetes or significant metabolic dysfunction should have any investigational peptide protocol reviewed by their endocrinologist or primary care physician alongside their supervising aesthetic medicine provider
Athletes, biohackers, and even everyday people dealing with injuries have turned to BPC-157 for its incredible benefits
The legal status of peptides in the UK (such as BPC-157, MK-677 etc) can appear slightly unclear
Lack of robust human clinical trials prevents confirmation of consistent outcomes, optimal dosing, or long-term safety
NNMT and lipid accumulation: in cell studies, reducing NNMT was associated with less stored fat